Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)

NCT05481749 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2023-02-14
Last updated
2025-06-26

Condition(s) studied

DementiaCognition Disorders in Old Age

Study summary

Neuropsychological tests currently considered to evaluate the cognitive performance of the oldest-old population (more than 80 years) are not adapted to this group population. This trial aims to determine the normal limits for this group population of a set of 18 neuropsychological test. Results may improve the diagnostic cognitive evaluation of this population.

Eligibility

Sex
ALL
Min age
80 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 80 or more years old * Residence at Comarca del Garraf * Able to be transfered to study center * Sufficient reading and writing capacity to carry out the neuropsychological tests, at the evaluator's discretion. Exclusion Criteria: * Patient at end-of-life situation or with a very short life expectancy (days-weeks). * Hospital admission in the previous 3 months. * History of relevant mental illness: major depression, psychosis, bipolar disorder, obsessive-compulsive disorder. * Disease of the central nervous system with possible cognitive impairment: Parkinson's disease, multiple sclerosis, brain tumor, stroke with cognitive impairment, epilepsy, severe traumatic brain injury. * History of alcoholism or substance abuse. * Severe sensory deficit that prevents performing neuropsychological tests, at the discretion of the evaluator. * Positive Shortened Spanish Informant Questionnaire for Cognitive Decline in the Elderly questionnaire (SS-IQCODE) or Lobo's Cognitive Mini-examination Test (spanish adaptation of Minimental of Folstein test) with a score \< 23 (20 in people with low schooling or illiteracy). * Dementia criteria according to the Diagnostic and Statistical Manual of Mental Disorders IV.

Primary outcome measure(s)

  • Cognitive Performance — This outcome will be evaluated at Memory Clinic Unit, following the enrollment visit. The evaluation of this outcome will last approximately 60 minutes.
    Cognitive performance will be evaluated by 18 neuropsychological test (quantitative scores) which cover all main cognitive domains (memory and learning, language, perceptual-motor abilities, executive functions and attention).

Trial sites (6)

FacilityCityRegionStatus
Centro de Salud Les Roquetes-Sant Pere de Ribes Sant Pere de Ribes Barcelona Recruiting
Centros de Salud Sitges Sitges Barcelona Recruiting
Centro de Salud Vilanova i la Geltrú 1 Vilanova i la Geltrú Barcelona Recruiting
Centro de Salud Vilanova i la Geltrú 2 Jaume I Vilanova i la Geltrú Barcelona Recruiting
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar Vilanova i la Geltrú Barcelona Recruiting
Centro de Salud Sant Pere de Ribes Sant Pere de Ribes Barcelone Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05481749 on ClinicalTrials.gov ↗ ← All trials in Spain